XML 39 R29.htm IDEA: XBRL DOCUMENT v3.21.2
Stock-Based Compensation Expense and Shareholders' Equity (Tables)
 3 Months Ended
Oct. 31, 2021
Stockholders' Equity and Stock-based Compensation [Abstract]  
Stock-based compensation expense Stock-based compensation expense related to stock options and Stock Awards is included in the Company’s condensed consolidated statements of operations as follows (in thousands):
Three Months Ended October 31,
20212020
Stock-based compensation expense$32,533 $28,394 
Net impact of deferred stock-based compensation(293)(310)
 Total stock-based compensation expense, net$32,240 $28,084 
Stock-based compensation expense is included in the following categories:
Cost of subscription and support revenue$3,348 $2,602 
Cost of license revenue182 251 
Cost of services revenue5,637 5,543 
Research and development8,614 7,247 
Sales and marketing7,489 5,977 
General and administrative6,970 6,464 
Total stock-based compensation expense$32,240 $28,084 
Schedule of Share-based Compensation, Restricted Stock Units Award Activity
A summary of the Company’s Stock Awards activity under the Company’s equity incentive plans is as follows:
 Stock Awards Outstanding
 Number of Stock Awards Outstanding Weighted Average Grant Date Fair Value
 Aggregate Intrinsic Value (in thousands)(1)
Balance as of July 31, 20212,394,968 $107.15 $275,900 
Granted1,512,995 $119.97 
Released(335,653)$99.22 $40,270 
Canceled(88,420)$107.92 
Balance as of October 31, 20213,483,890 $113.47 $438,029 
Expected to vest as of October 31, 20213,483,890 $113.47 $438,029 
(1) Aggregate intrinsic value at each period end represents the total market value of Stock Awards at the Company’s closing stock price of $125.73 and $115.20 on October 31, 2021 and July 31, 2021, respectively. Aggregate intrinsic value for released Stock Awards represents the total market value of released Stock Awards at date of release.
Schedule of Share-based Compensation, Stock Options, Activity
Stock option activity under the Company’s equity incentive plans is as follows:
 Stock Options Outstanding
 Number of Stock Options Outstanding Weighted Average Exercise PriceWeighted Average Remaining Contractual Life
 Aggregate Intrinsic Value(1)
(in years) (in thousands)
Balance as of July 31, 202125,278 $17.39 5.0$2,472 
Granted— 
Exercised(1,518)$10.90 $168 
Canceled— 
Balance at October 31, 202123,760 $17.81 4.1$2,564 
Vested and expected to vest as of October 31, 202123,760 $17.81 4.1$2,564 
Exercisable as of October 31, 202123,760 $17.81 4.1$2,564 
(1) Aggregate intrinsic value at each period end represents the difference between the Company’s closing stock price of $125.73 and $115.20 on October 31, 2021 and July 31, 2021, respectively, and the exercise price of outstanding options. Aggregate intrinsic value for exercised options represents the difference between the Company’s stock price at date of exercise and the exercise price.
Common Stock Reserved for Issuance As of October 31, 2021 and July 31, 2021, the Company had reserved shares of common stock for future issuance as follows:
October 31, 2021July 31, 2021
Exercise of stock options to purchase common stock23,760 25,278 
Vesting of stock awards3,483,890 2,394,968 
Shares available under stock plans3,590,878 5,014,069 
Total common stock reserved for issuance7,098,528 7,434,315